Amantadine, a generic drug created in the 1970s to treat seasonal flu might become a new weapon to use along with Tamiflu if a bird flu pandemic occurs.
Initial tests among the first avian flu victims in Southeast Asia suggested the virus was resistant to amantadine, The Wall Street Journal reported Wednesday. But evidence is mounting that amantadine might be effective against some of the 130 strains of the H5N1 virus that have been sequenced.
World Health Organization officials in Geneva told The Journal the H5N1 strains found in Vietnam, Thailand and Cambodia seem to be mostly resistant, but strains from China, Indonesia and Turkey seem to be somewhat sensitive to the drug.
Plans currently involve using Tamiflu should the virus evolve and cause a pandemic. However, WHO experts note amantadine and its older cousin, rimantadine, are produced by many generic drug makers, offering a potentially huge supply at costs far lower than Tamiflu's.
Copyright 2006 by United Press International
Related stories:
Interferon as long-term treatment for hepatitis C not effective
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.
Flu deaths could be reduced thanks to cancer research
(PhysOrg.com) -- Cells involved in the body’s immune response to cancer are also implicated in influenza infection and could be targeted in new flu vaccination strategies, scientists at Oxford University have discovered.
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal
Nature Biotechnology.
Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis
University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.
Discovery opens door for drugs to fight bird flu, other influenza epidemics
Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza.
Study shows why cigarette smoke makes flu, other viral infections worse
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the
Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage.
Improved culture system for hepatitis C virus infection
A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate possible treatments. The novel cell line, described in the July 16 issue of
PLoS ONE, will allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide. Currently, there is no animal model that is effective for testing such therapies.
Fruit fly gene study could yield new flu treatments
Scientists may be able to stave off influenza infection by targeting one of more than 100 proteins inside host cells on which the virus depends. These potential drug targets are the result of a study in which researchers tested the ability of a modified influenza virus to infect fruit fly cells.